
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Marc Arbyn, Lan Xu, Cindy Simoens, et al.
Cochrane library (2018) Vol. 2020, Iss. 3
Open Access | Times Cited: 517
Marc Arbyn, Lan Xu, Cindy Simoens, et al.
Cochrane library (2018) Vol. 2020, Iss. 3
Open Access | Times Cited: 517
Showing 1-25 of 517 citing articles:
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
The Lancet Global Health (2019) Vol. 8, Iss. 2, pp. e191-e203
Open Access | Times Cited: 3352
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
The Lancet Global Health (2019) Vol. 8, Iss. 2, pp. e191-e203
Open Access | Times Cited: 3352
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network (2020) Vol. 18, Iss. 6, pp. 660-666
Open Access | Times Cited: 291
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network (2020) Vol. 18, Iss. 6, pp. 660-666
Open Access | Times Cited: 291
Human Papillomavirus Vaccines: An Updated Review
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 232
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 232
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Timothy Palmer, Lynn Wallace, Kevin Pollock, et al.
BMJ (2019), pp. l1161-l1161
Open Access | Times Cited: 211
Timothy Palmer, Lynn Wallace, Kevin Pollock, et al.
BMJ (2019), pp. l1161-l1161
Open Access | Times Cited: 211
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Supitcha Kamolratanakul, Punnee Pitisuttithum
Vaccines (2021) Vol. 9, Iss. 12, pp. 1413-1413
Open Access | Times Cited: 173
Supitcha Kamolratanakul, Punnee Pitisuttithum
Vaccines (2021) Vol. 9, Iss. 12, pp. 1413-1413
Open Access | Times Cited: 173
Human papillomavirus vaccination and cervical cancer risk
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 102
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 102
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023
Jan Willem Cohen Tervaert, Manuel Martínez‐Lavín, Luis J. Jara, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103287-103287
Open Access | Times Cited: 73
Jan Willem Cohen Tervaert, Manuel Martínez‐Lavín, Luis J. Jara, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103287-103287
Open Access | Times Cited: 73
Updates on HPV Vaccination
Ojone Illah, Adeola Olaitan
Diagnostics (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 67
Ojone Illah, Adeola Olaitan
Diagnostics (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 67
Updates on cervical cancer prevention
David Viveros‐Carreño, Andreína Fernándes, René Pareja
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 394-402
Closed Access | Times Cited: 56
David Viveros‐Carreño, Andreína Fernándes, René Pareja
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 394-402
Closed Access | Times Cited: 56
CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer
Xinjie Zhao, Li Yang, Jigang Pan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Xinjie Zhao, Li Yang, Jigang Pan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
Marc Arbyn, Lan Xu
Expert Review of Vaccines (2018) Vol. 17, Iss. 12, pp. 1085-1091
Closed Access | Times Cited: 159
Marc Arbyn, Lan Xu
Expert Review of Vaccines (2018) Vol. 17, Iss. 12, pp. 1085-1091
Closed Access | Times Cited: 159
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males
Hanna Bergman, Brian S Buckley, Gemma Villanueva, et al.
Cochrane library (2019) Vol. 2019, Iss. 11
Open Access | Times Cited: 136
Hanna Bergman, Brian S Buckley, Gemma Villanueva, et al.
Cochrane library (2019) Vol. 2019, Iss. 11
Open Access | Times Cited: 136
Human Papillomavirus–Associated Oropharyngeal Cancer: Review of Current Evidence and Management
Eunice You, Mélissa Henry, Anthony Zeitouni
Current Oncology (2019) Vol. 26, Iss. 2, pp. 119-123
Open Access | Times Cited: 125
Eunice You, Mélissa Henry, Anthony Zeitouni
Current Oncology (2019) Vol. 26, Iss. 2, pp. 119-123
Open Access | Times Cited: 125
Peptides, Antibodies, Peptide Antibodies and More
Nicole Hartwig Trier, Per Brinch Hansen, Gunnar Houen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6289-6289
Open Access | Times Cited: 109
Nicole Hartwig Trier, Per Brinch Hansen, Gunnar Houen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6289-6289
Open Access | Times Cited: 109
Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis
Julia Brotherton, Alison C Budd, Christopher Rompotis, et al.
Papillomavirus Research (2019) Vol. 8, pp. 100177-100177
Open Access | Times Cited: 105
Julia Brotherton, Alison C Budd, Christopher Rompotis, et al.
Papillomavirus Research (2019) Vol. 8, pp. 100177-100177
Open Access | Times Cited: 105
P value–driven methods were underpowered to detect publication bias: analysis of Cochrane review meta-analyses
Luis Furuya‐Kanamori, Chang Xu, Lifeng Lin, et al.
Journal of Clinical Epidemiology (2019) Vol. 118, pp. 86-92
Closed Access | Times Cited: 93
Luis Furuya‐Kanamori, Chang Xu, Lifeng Lin, et al.
Journal of Clinical Epidemiology (2019) Vol. 118, pp. 86-92
Closed Access | Times Cited: 93
HPV vaccination and cancer prevention
Antonios Athanasiou, Sarah Bowden, Maria Paraskevaidi, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2020) Vol. 65, pp. 109-124
Closed Access | Times Cited: 91
Antonios Athanasiou, Sarah Bowden, Maria Paraskevaidi, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2020) Vol. 65, pp. 109-124
Closed Access | Times Cited: 91
Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus
Claus Wittekindt, Steffen Wagner, Ayman Bushnak, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 6, pp. 375-382
Open Access | Times Cited: 81
Claus Wittekindt, Steffen Wagner, Ayman Bushnak, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 6, pp. 375-382
Open Access | Times Cited: 81
British Gynaecological Cancer Society (BGCS) cervical cancer guidelines: Recommendations for practice
Nick Reed, Janos Balega, Tara Barwick, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2020) Vol. 256, pp. 433-465
Closed Access | Times Cited: 80
Nick Reed, Janos Balega, Tara Barwick, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2020) Vol. 256, pp. 433-465
Closed Access | Times Cited: 80
The European response to the WHO call to eliminate cervical cancer as a public health problem
Marc Arbyn, Murat Gültekin, Philippe Morice, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 2, pp. 277-284
Open Access | Times Cited: 80
Marc Arbyn, Murat Gültekin, Philippe Morice, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 2, pp. 277-284
Open Access | Times Cited: 80
Resilience of HPV vaccine uptake in Denmark: Decline and recovery
Peter Reinhard Hansen, Matthias Schmidtblaicher, Noel T. Brewer
Vaccine (2020) Vol. 38, Iss. 7, pp. 1842-1848
Open Access | Times Cited: 78
Peter Reinhard Hansen, Matthias Schmidtblaicher, Noel T. Brewer
Vaccine (2020) Vol. 38, Iss. 7, pp. 1842-1848
Open Access | Times Cited: 78
HPV Vaccination: An Underused Strategy for the Prevention of Cancer
Gilla K. Shapiro
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3780-3792
Open Access | Times Cited: 66
Gilla K. Shapiro
Current Oncology (2022) Vol. 29, Iss. 5, pp. 3780-3792
Open Access | Times Cited: 66
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
Violante Di Donato, Giuseppe Caruso, Marco Petrillo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 410-410
Open Access | Times Cited: 64
Violante Di Donato, Giuseppe Caruso, Marco Petrillo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 410-410
Open Access | Times Cited: 64
Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells
Hongmin Chen, Xiaojie Feng, Ling Gao, et al.
Artificial Cells Nanomedicine and Biotechnology (2021) Vol. 49, Iss. 1, pp. 240-249
Open Access | Times Cited: 61
Hongmin Chen, Xiaojie Feng, Ling Gao, et al.
Artificial Cells Nanomedicine and Biotechnology (2021) Vol. 49, Iss. 1, pp. 240-249
Open Access | Times Cited: 61